FDA snubs Novartis bid to repurpose inflammation drug for heart attacks
By John Miller ZURICH: The U.S. Food and Drug Administration has rejected Novartis’s bid to repurpose a drug now approved for rare inflammatory diseases to be used in a group…
Uttar Pradesh government planned to open Six Pharma Parks
Six Pharma Parks has been planned to set-up in the Uttar Pradesh state as the state has been received an investment commitment of about Rs 5,000-6,000 crore from domestic and…
Piramal weighs $1bn contract pharma sale
Billionaire Ajay Piramal is considering a sale of his contract pharmaceutical operations, which could fetch around $1 billion, people with knowledge of the matter said. The tycoon’s Piramal Enterprises is…
Trevena’s opioid painkiller fails to get FDA panel backing
By Saumya Joseph and Ankur Banerjee Trevena Inc’s opioid injection for managing acute pain failed to win the backing of an advisory panel to the Food and Drug Administration on…
CHENNAI: State to spend Rs 35 lakh more for common drug
CHENNAI: The state health department will soon have to spend about Rs 35 lakh more a month for a commonly used drug in labour rooms of government hospitals following the…
Walgreens revenue hit by weakness in personal care products, OTC drugs
By Manas Mishra Walgreens Boots Alliance Inc came up short of analysts’ estimates for quarterly revenue on Thursday, as sales of personal care products and over-the-counter drugs fell both in…
UP to open 6 pharma parks; gets Rs 5,000-6,000 cr commitment
The Uttar Pradesh government is planning to open six pharma parks across the state and has received an investment commitment of about Rs 5,000-6,000 crore from domestic and multinational pharma…
China approves 17 anti-cancer drugs for medical insurance coverage
SHANGHAI: China has approved 17 anti-cancer drugs for inclusion in its national health insurance system, the government said on Wednesday, part of its efforts to make cancer treatment more affordable…
Affimed puts on hold cancer drug trial after patient death
Drug developer Affimed N.V. on Monday put on hold the testing of its experimental cancer drug following the death of a patient and two life-threatening events. The company’s shares slumped…
Akcea Therapeutics genetic disease treatment gets FDA approval
Akcea Therapeutics Inc said on Friday its treatment, developed along with Ionis Pharmaceuticals , which targets a rare genetic disease was approved by the U.S. Food and Drug Administration. Akcea’s…
